| Authors: |
Ustianowski A; North Manchester General Hospital, Manchester, UK., Levin MJ; University of Colorado School of Medicine, Aurora, CO, USA., De Wit S; Division of Infectious Diseases, Saint-Pierre University Hospital, Université Libre de Bruxelles, Brussels, Belgium., Launay O; Université Paris Cité, Paris, France.; Inserm F-CRIN, I-REIVAC, Paris, France.; Assistance Publique Hôpitaux de Paris, Paris, France., Veekmans B; Anima Research Center, Alken, Belgium., Rampling T; University College London Hospitals NHS Foundation Trust, London, UK., Sullivan JG; Parkway Medical Center, Birmingham, AL, USA., Vishnepolsky M; Kidney Specialists of Southern Nevada, Las Vegas, NV, USA.; DaVita Clinical Research, Las Vegas, NV, USA., Wijewardane P; Baptist Health Center for Clinical Research, Little Rock, AR, USA., Fawadleh Y; Vaccines & Immune Therapies, Clinical Operations, BioPharmaceuticals R&D, AstraZeneca, Mississauga, ON, Canada., Zhang H; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Li M; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Wickramarachchi D; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Sharbaugh A; Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Durham, NC, USA., Beavon R; Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Thissen J; Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Hirao L; Vaccines & Immune Therapies, Biopharmaceuticals R&D, AstraZeneca, 1 Medimmune Way, Gaithersburg, MD, 20878, USA., Dzutseva V; Vaccines & Immune Therapies, Biopharmaceuticals R&D, AstraZeneca, 1 Medimmune Way, Gaithersburg, MD, 20878, USA., Seegobin S; Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Streicher K; Vaccines & Immune Therapies, Biopharmaceuticals R&D, AstraZeneca, 1 Medimmune Way, Gaithersburg, MD, 20878, USA., Kiazand A; Global Patient Safety, Chief Medical Office, R&D, AstraZeneca, Gaithersburg, MD, USA., Esser MT; Vaccines & Immune Therapies, Biopharmaceuticals R&D, AstraZeneca, 1 Medimmune Way, Gaithersburg, MD, 20878, USA., Chang LJ; Vaccines & Immune Therapies, Biopharmaceuticals R&D, AstraZeneca, 1 Medimmune Way, Gaithersburg, MD, 20878, USA., Perez JL; Vaccines & Immune Therapies, Biopharmaceuticals R&D, AstraZeneca, 1 Medimmune Way, Gaithersburg, MD, 20878, USA., Cohen TS; Vaccines & Immune Therapies, Biopharmaceuticals R&D, AstraZeneca, 1 Medimmune Way, Gaithersburg, MD, 20878, USA. taylor.cohen@astrazeneca.com. |
